Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201303043 Principal Investigator: Lockhart, A. Craig
Title: Phase II Study of Levocetirizine in Combination with Capecitabine + Bevacizumab to Overcome Resistance to Anti-angiogenic Therapy in Patients with Refractory Colorectal Cancer
Description: The purpose of this research study is to look at how adding a drug called levocetirizine to a standard treatment for colorectal cancer affects how the patient responds to the treatment, as well as looking at the side effects of this type of treatment....MORE
___________________________________________________________________________________________________
 Number: 201107017 Principal Investigator: Tan, Benjamin
Title: A Phase I Dose-Escalation Trial of Biweekly Intraperitoneal Oxaliplatin with Systemic Capecitabine and Bevacizumab Following Cytoreduction in Patients with Peritoneal Carcinomatosis from Appendiceal or Colorectal Cancer
Description: The main purpose of this research is to evaluate an intraperitoneal treatment for cancer following a surgical attempt to remove as much or all of the cancer as possible. The goals of this study are to determine the safety and side effects of this treatment, and to learn the maximum tolerated dose (...MORE
___________________________________________________________________________________________________
 Number: CTSU S1406 Principal Investigator: Tan, Benjamin
Title: Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Description: The purpose of this study is to compare any good and bad effects of using vemurafenib along with the usual chemotherapy, cetuximab and irinotecan,to using the usual chemotherapy approach alone in pateients with BRAF mutation positive colorectal cancer....MORE
___________________________________________________________________________________________________
 Number: CALGB E7208 Principal Investigator: Tan, Benjamin
Title: A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab, in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy
Description: The purpose of the study is to determine whether an investigational drug, ramucirumab, is safe and effective when given with irinotecan and cetuximab....MORE
___________________________________________________________________________________________________
 Number: CALGB 80702 Principal Investigator: Tan, Benjamin
Title: A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Description: In this study, we will evaluate the effects (good and bad) of an oral drug called celecoxib when given in combination with FOLFOX chemotherapy. ...MORE
___________________________________________________________________________________________________
 Number: 201411090 Principal Investigator: Tan, Benjamin
Title: An Open Label Expanded Access Study of TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to or Failing Standard Chemotherapy
Description: The he purpose of this research study is to provide access to the investigational drug, TAS-102, to patients with metastatic colorectal cancer that is refractory to or has failed available standard chemotherapy treatment....MORE
___________________________________________________________________________________________________
 Number: 201404049 Principal Investigator: Tan, Benjamin
Title: A Phase 1/2 Therapeutic, Open Label, Multi-Center Clinical Trial of NPC-1C, a Chimeric Monoclonal Antibody, in Adults with Recurrent, Locally Advanced Unresectable or Metastatic Pancreatic and Colorectal Cancer After Standard Therapy
Description: The purpose of this study is to evaluate the safety and effectiveness of the experimental drug called NPC-1C in patients with metastatic pancractic or colorectal cancer....MORE
___________________________________________________________________________________________________
 Number: 201202001 Principal Investigator: Zuckerman, Darryl
Title: A Phase III Clinical Trial Evaluating TheraSphere in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy
Description: The purpose of this research study is to examine whether adding treatment with TheraSphere early in the current standard for second-line chemotherapy treatment of metastatic colorectal cancer is better than the current treatment alone. Better means slowing or stopping the growth of liver tumors ...MORE
___________________________________________________________________________________________________
 Number: 201110005 Principal Investigator: James, Aimee
Title: Systems Intervention to Promote Colorectal Cancer Screening/ Program for the Elimination of Cancer Disparities
Description: The purpose of this part of the study is to understand people’s practices regarding health and cancer screening. You will be asked to talk with Dr. James or her designated staff member. We will ask questions about your background, your health and your thoughts and experiences about preventive care....MORE
___________________________________________________________________________________________________
 Number: 201309008 Principal Investigator: Deshpande, Anjali
Title: Examining Comorbidity Burden and Patient-Reported Outcomes of CRC Survivors
Description: The purpose of this research study is to understand how pre-existing chronic health conditions affect patient-reported outcomes such as cancer symptoms, treatment side-effects, physical and emotional functioning, and self-rated health among newly diagnosed colorectal cancer patients early in their t...MORE
___________________________________________________________________________________________________
 Number: 201301164 Principal Investigator: Liu, Ta-chiang
Title: Genetic, molecular, and pathologic analysis of colon cancer
___________________________________________________________________________________________________